Beyond Air has submitted a supplement application for its second-generation LungFit PH 2 device for treating PPHN.

A trial of Insmed’s TPIP suggests daily doses of the inhaled dry powder are well tolerated and may improve blood flow in ...

The first participant has been dosed in a Phase 1 trial testing F230 for the treatment of pulmonary arterial hypertension.

Turning 30 is something columnist Anna Jeter never expected to do because of a childhood PH diagnosis. She grapples with the ...

A Phase 2a study of HB-1614, an oral therapy candidate, suggested the medication is safe and may improve exercise capacity and quality of life in adults with pulmonary hypertension associated with ...